AMSTERDAM, May 10, 2016 /PRNewswire/ --
More than 500 neurosurgeons, radiation oncologists, physicists and other health care providers from 170 global centers will gather next week (May 15-19) in Amsterdam for the 18th International Leksell Gamma Knife® Society Meeting to discuss the latest developments in the field of Gamma Knife radiosurgery.
The scientific program focuses on the growing and integral role stereotactic radiosurgery has in the treatment of complex brain disorders. More than 180 presentations will cover a range of topics including metastatic tumor treatment with targeted immunotherapies in combination with Gamma Knife radiosurgery with focus on quality of life and effects on neurocognition. The program also includes lectures on the cost effectiveness of stereotactic radiosurgery, radiosurgery for gliomas and the role of Gamma Knife radiosurgery in the treatment of functional disorders such as essential tremor.
"This international, multidisciplinary meeting is unique in its depth and breadth of scientific evidence presentations for brain radiosurgery," says Dr. Guus Beute, neurosurgeon at Elisabeth Tweesteden Ziekenhuis (ETZ, Tilburg, the Netherlands) and co-chairman of the 18th International Leksell Gamma Knife Society. "We are honored to welcome delegates from more than 40 countries and appreciate their critical contributions to this important forum."
"Gamma Knife radiosurgery is a non-invasive treatment and is increasingly utilized as an adjunct or alternative option to traditional open surgery and whole brain radiation in either a single session or in multiple sessions," says Dr. Patrick Hanssens, ETZ radiation oncologist and co-chairman. "This meeting will provide further evidence supporting the use of this cost-effective technique for treating a wide variety of neurological conditions."
About the Leksell Gamma Knife Society
The Leksell Gamma Knife Society was established in 1989 to provide a forum for Gamma Knife users to share best practices, clinical techniques and advanced scientific research in the quest to improve patient outcomes. The biennial meeting results in a large number of clinical publications, in recent years published as a supplement to Journal of Neurosurgery.
The Society plays an important role in increasing the visibility and acceptance of Gamma Knife surgery in the worldwide medical community, among healthcare providers and among patients. The open sharing of results and experiences allows all Gamma Knife users to maintain leadership in the field of intracranial radiosurgery, based on the most recent clinical advancements.
For further information, please contact:
Thérèse Nathanaelson, Leksell Gamma Knife Society Communications Manager
Tel: +46-8587-25717, e-mail: email@example.com
Time zone: CET: Central European Time
SOURCE Leksell Gamma Knife Society